A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data

导出原文传递

翻译打印收藏纠错

作者： Parks,D. ^[1] ; Lin,X. ^[2] ; Painter,J.L. ^[3] ; Cheng,J. ^[4] ; Hunt,C.M. ^[5] ; Spraggs,C.F. ^[6] ; Nelson,J.J. ; Curtis,L. ; Menius,J.A. ; Lee,K.R.

作者单位： Genetics, GlaxoSmithKline, Stevenage, United Kingdom ^[1] Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC, United States ^[2] Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Stockley Park, United Kingdom ^[3] GlaxoSmithKline, Collegeville, PA, United States ^[4] GlaxoSmithKline, Research Triangle Park, NC, United States ^[5] Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Research Triangle Park, NC, United ^[6]

关键词 Hy's law Liver chemistry elevation Liver toxicity Multivariate outlier detection Pharmacoepidemiology

发布时间 2014-04-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交